Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

NCT00060671 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Follicular
Lymphoma, Mixed-Cell, Follicular
Lymphoma, Small Cleaved-Cell, Follicular
Lymphoma, Low-Grade

Interventions

DRUG: rituximab
DRUG: Pixantrone (BBR 2778)

Sponsor

CTI BioPharma